Patient letter
We advice our patients to give the following letter, listing all the drugs on this website, to all of their health care professionals (including their general practitioner, dentist and pharmacist). Although the most appropriate treatment of Brugada syndrome is under discussion, avoidance of potentially proarrhythmic drugs and treatment of fever (which is a well-known trigger of cardiac events in Brugada syndrome) are generally accepted to be an important part of (prophylactic) treatment. However, some patients may (only) be appropriately treated with an implantable cardioverter-defibrillator. Some drugs may have an antiarrhythmic effect and may be used favorably in the acute or chronic setting (see potential antiarrhythmic drugs).
This patient letter has been translated into several languages by our colleagues. When you would appreciate to receive an email when the content of the letter is changed importantly (i.e. drugs added, removed or with changed qualification), please send us your update request here.
| Flag | Language | Translation | Date |
 |
Catalan | Prof. J. Brugada, MD, PhD | February 2010 |
 |
Dutch | P.G. Postema, MD | February 2010 |
 |
English | P.G. Postema, MD | February 2010 |
 |
French | Prof. V. Probst, MD, PhD | February 2010 |
 |
German | C. Veltmann, MD | February 2010 |
 |
Hebrew | S. Viskin, MD | February 2010 |
 |
Italian | Prof. S.G. Priori, MD, PhD | February 2010 |
 |
Japanese | Prof. M. Hiraoka, MD, PhD | February 2010 |
 |
Norwegian | Prof. K. Gjesdal, MD, PhD under construction |
February 2010 |
 |
Portuguese | A.R. Perez Riera, MD | February 2010 |
 |
Spanish | Prof. J. Brugada, MD, PhD | February 2010 |
 |
Swedish | Prof. L. Bergfeldt, MD, PhD | February 2010 |
 |
Thai | Prof. K. Nademanee, MD, PhD / Dr. G. Veerakul | February 2010 |